Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Artificial intelligence identifies prostate cancer with near-perfect accuracy
A study published in The Lancet Digital Health by UPMC and University of Pittsburgh, USA, researchers…
Daiichi Sankyo and AstraZeneca Enter New Global Development Collaboration for ADC DS-1062
Daiichi Sankyo announced today that it has entered into a global development and commercialization agreement…
A novel tissue imaging system accelerates cancer diagnosis
Cancer diagnosis requires a lengthy process of multiple analyses of tissue biopsies, impeding the quick…
Pancreatic cancer resists personalised medicine — what researchers are doing to fight back
A team led by University of Arizona researchers is taking a new, patient-directed approach to treating pancreatic cancer. Rather than…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.